LYELNasdaq United States
Market cap
$360.459 M
$14.71 +3.52%
Close of 7 Aug 2026
Revenue
$36.0K
#3637 by revenue
Earnings
-$274.4M
Loss-making
Shares outstanding
24,505,141
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Lyell Immunopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.